Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

September 01, 1995; Volume 274,Issue 3

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1573;
  • You have access
    Increases in non-N-methyl-D-aspartate glutamatergic transmission, but no change in gamma-aminobutyric acidB transmission, in CA1 neurons during withdrawal from in vivo chronic ethanol treatment.
    A Molleman and H J Little
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1035-1041;
  • You have access
    Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018.
    H Kushida, S Nomura, O Morita, Y Harasawa, M Suzuki, M Nakano, K Ozawa and M Kunihara
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1042-1053;
  • You have access
    The effects of chronic amphetamine treatment on prenatal ethanol-induced changes in dopamine receptor function: electrophysiological findings.
    R Y Shen, J H Hannigan and L A Chiodo
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1054-1060;
  • You have access
    Effect of tolbutamide on the rate of fatigue and recovery in frog sartorius muscle.
    A Comtois, P Light and J M Renaud
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1061-1066;
  • You have access
    Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
    J R Cockcroft, P J Chowienczyk, S E Brett, C P Chen, A G Dupont, L Van Nueten, S J Wooding and J M Ritter
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1067-1071;
  • You have access
    Efflux of intracellular colchicine in lymphocytes with colchicine-specific Fab fragments.
    O N Chappey, E Niel, M Debray, J L Wautier and J M Scherrmann
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1072-1076;
  • You have access
    Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    J Jakubík, L Bacáková, E E el-Fakahany and S Tucek
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1077-1083;
  • You have access
    Characterization of 125I-endothelin-1 binding to rat and rabbit renal microvasculature.
    R M Edwards and W Trizna
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1084-1089;
  • You have access
    Trifluoperazine modulates [3H]resiniferatoxin binding by human and rat vanilloid (capsaicin) receptors and affects 45Ca uptake by adult rat dorsal root ganglion neurones.
    G Acs, M Palkovits and P M Blumberg
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1090-1098;
  • You have access
    In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity.
    H Nakamura, J Uetrecht, A E Cribb, M A Miller, N Zahid, J Hill, P D Josephy, D M Grant and S P Spielberg
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1099-1104;
  • You have access
    Effects of the benzodiazepine inverse agonist RO19-4603 on the maintenance of tolerance to a single dose of ethanol.
    H L June, S E Duemler, T L Greene, J A Williams, M Lin, S L Devaraju, S H Chen, M J Lewis and J M Murphy
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1105-1112;
  • You have access
    Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    M D Swedberg, P Jacobsen and T Honoré
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1113-1121;
  • You have access
    Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney.
    A Mancinelli, A Longo, K Shanahan and A M Evans
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1122-1128;
  • You have access
    Selective peptide and nonpeptide ligands differentially bind to angiotensin II AT2 receptor and a non-angiotensin II CGP42112 binding site.
    G M Ciuffo and J M Saavedra
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1129-1134;
  • You have access
    Blood pressure (BP) and renal vasoconstrictor responses to acute blockade of nitric oxide: persistence of renal vasoconstriction despite normalization of BP with either verapamil or sodium nitroprusside.
    C Baylis, S Masilamani, G Losonczy, L Samsell, P Harton and K Engels
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1135-1141;
  • You have access
    Quantitative and qualitative aspects of the hibernation-related reduction of morphine physical dependence in the ground squirrel (Citellus lateralis).
    T A Beaver, F C Lewis, J R Newman and A L Beckman
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1142-1153;
  • You have access
    Glucocorticoid receptor activation potentiates the morphine-induced adaptive increase in dopamine D-1 receptor efficacy in gamma-aminobutyric acid neurons of rat striatum/nucleus accumbens.
    A N Schoffelmeer, T J De Vries, L J Vanderschuren, G H Tjon, P Nestby, G Wardeh and A H Mulder
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1154-1160;
  • You have access
    Specificity of p-aminohippurate transport system in the OK kidney epithelial cell line.
    J Nagai, M Takano, K Hirozane, M Yasuhara and K Inui
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1161-1166;
  • You have access
    Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia.
    B R Shivakumar, S V Kolluri and V Ravindranath
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1167-1173;
  • You have access
    Blunting of renal excretory responses to acute volume expansion by nicotine: role of renal nerves.
    K P Patel, P L Zhang and W G Mayhan
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1174-1181;
  • You have access
    Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine.
    L H Parsons, G F Koob and F Weiss
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1182-1191;
  • You have access
    Enantioselective effects of experimental diabetes mellitus on the metabolism of ibuprofen.
    X Oian and S D Hall
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1192-1198;
  • You have access
    Cerebrovascular permeability changes during experimental meningitis in the rat.
    K M Boje
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1199-1203;
  • You have access
    Stimulation by aminooxyacetate of fluorescein uptake in rat renal tubules in vitro: role of intracellular alpha-ketoglutarate.
    A A Nikiforov
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1204-1208;
  • You have access
    Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation.
    J Liu and B Moghaddam
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1209-1215;
  • You have access
    Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity.
    D Aharony, C K Buckner, J L Ellis, S V Ghanekar, A Graham, J S Kays, J Little, S Meeker, S C Miller and B J Undem
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1216-1221;
  • You have access
    SB 203220: a novel angiotensin II receptor antagonist and renoprotective agent.
    D P Brooks, L C Contino, B G Short, C Gowan, W Trizna and R M Edwards
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1222-1227;
  • You have access
    The pH dependence of cocaine interaction with cardiac sodium channels.
    W J Crumb and C W Clarkson
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1228-1237;
  • You have access
    ATP inhibits the synaptic release of acetylcholine in submucosal neurons.
    C Barajas-López, M J Muller, B Prieto-Gómez and R Espinosa-Luna
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1238-1245;
  • You have access
    Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury.
    T Murohara, J P Guo and A M Lefer
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1246-1253;
  • You have access
    SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
    L A Marshall, R H Hall, J D Winkler, A Badger, B Bolognese, A Roshak, P L Flamberg, C M Sung, M Chabot-Fletcher and J L Adams
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1254-1262;
  • You have access
    Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.
    E E Codd, R P Shank, J J Schupsky and R B Raffa
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1263-1270;
  • You have access
    Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
    G Chen and D J Waxman
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1271-1277;
  • You have access
    Intracellular alpha-ketoglutarate controls the efficacy of renal organic anion transport.
    J B Pritchard
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1278-1284;
  • You have access
    Fentanyl-related 4-heteroanilido piperidine OHM3295 augments splenic natural killer activity and induces analgesia through opioid receptor pathways.
    M L Baker, L L Brockunier, J R Bagley, C P France and D J Carr
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1285-1292;
  • You have access
    Pharmacological characterization of the muscarinic receptor subtype mediating contraction of human peripheral airways.
    N Watson, H Magnussen and K F Rabe
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1293-1297;
  • You have access
    Targeting 6-thioguanine to the kidney with S-(guanin-6-yl)-L-cysteine.
    A A Elfarra, R J Duescher, I Y Hwang, A R Sicuri and J A Nelson
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1298-1304;
  • You have access
    The role of serotonin in the effects of opioids in squirrel monkeys responding under a titration procedure: I. Kappa opioids.
    K R Powell and L A Dykstra
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1305-1316;
  • You have access
    Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
    D L Hammond, P E Stewart and L Littell
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1317-1324;
  • You have access
    A primate model of polydrug abuse: cocaine and heroin combinations.
    N K Mello, S S Negus, S E Lukas, J H Mendelson, J W Sholar and J Drieze
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1325-1337;
  • You have access
    Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators.
    J D Winkler, A N Fonteh, C M Sung, J D Heravi, A B Nixon, M Chabot-Fletcher, D Griswold, L A Marshall and F H Chilton
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1338-1347;
  • You have access
    Furosemide renal excretion rate and the effects of the diuretic on different tubular sites are modified by endogenous dopamine in normohydrated rats.
    S Nowicki, J A Opezzo, G Levin, D Gonzalez and M M Elias
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1348-1354;
  • You have access
    Relative potencies of volatile anesthetics in altering the kinetics of ion channels in BC3H1 cells.
    R E Wachtel
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1355-1361;
  • You have access
    Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
    O Takenaka, T Horie, H Suzuki and Y Sugiyama
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1362-1369;
  • You have access
    JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer.
    K Toide, Y Iwamoto, T Fujiwara and H Abe
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1370-1378;
  • You have access
    Saralasin suppresses arrhythmias in an isolated guinea pig ventricular free wall model of simulated ischemia and reperfusion.
    G P Thomas, S E Howlett and G R Ferrier
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1379-1386;
  • You have access
    Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors.
    G J Keil and G E Delander
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1387-1392;
  • You have access
    The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist.
    D C Bolser, D J Blythin, R W Chapman, R W Egan, J A Hey, C Rizzo, S C Kuo and W Kreutner
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1393-1398;
  • You have access
    Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models.
    D A Hosford, Y Wang, C C Liu and O C Snead
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1399-1403;
  • You have access
    The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
    M R Szewczak, R Corbett, D K Rush, C A Wilmot, P G Conway, J T Strupczewski and M Cornfeldt
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1404-1413;
  • You have access
    Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
    P M Callahan and K A Cunningham
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1414-1424;
  • You have access
    Pharmacological characterization of purinoceptor-mediated constriction of submucosal arterioles in guinea pig ileum.
    J J Galligan, A Herring and T Harpstead
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1425-1430;
  • You have access
    Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat.
    D Wu, S V Otton, W Kalow and E M Sellers
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1431-1437;
  • You have access
    Cyclosporin A affects red blood cell deformability in vivo but not in vitro in guinea pig.
    O K Başkurt, U K Sentürk, N Dayan, V Küçükatay, M Isbir, A Erkiliç and I Kaputlu
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1438-1442;
  • You have access
    Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice.
    P C Contreras, C Steffler, E Yu, K Callison, D Stong and J L Vaught
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1443-1449;
  • You have access
    Inactivation of Escherichia coli-expressed rabbit cytochrome P-450 2C enzymes by 17 beta-substituted steroids.
    P A Klekotka, T H Richardson, E F Johnson and J R Halpert
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1450-1455;
  • You have access
    Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein in the rat.
    J A Schetz, C A Mayr, J E Taylor, M Rosenblatt, M Chorev and T P Davis
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1456-1462;
  • You have access
    The pharmacological modulation of angiogenesis in chronic granulomatous inflammation.
    P R Colville-Nash, C A Alam, I Appleton, J R Brown, M P Seed and D A Willoughby
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1463-1472;
  • You have access
    Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe.
    K Y Little, F I Carroll and B J Cassin
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1473-1483;
  • You have access
    Regulation of allosteric coupling and function of stably expressed gamma-aminobutyric acid (GABA)A receptors by chronic treatment with GABAA and benzodiazepine agonists.
    R L Klein, M P Mascia, P C Harkness, K L Hadingham, P J Whiting and R A Harris
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1484-1492;
  • You have access
    Calcium channel activation mobilizes calcium from a restricted pericellular region surrounding canine coronary artery smooth muscle cells.
    E S Wheeler-Clark and L M Buja
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1493-1506;
  • You have access
    Mechanisms underlying endothelium-independent relaxation by acetylcholine in canine retinal and cerebral arteries.
    N Toda, J X Zhang, K Ayajiki and T Okamura
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1507-1512;
  • You have access
    Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cells.
    M M Belcheva, S Gucker, D M Chuang, W G Clark, L B Jefcoat, R J McHale, G Toth, A Borsodi and C J Coscia
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1513-1523;
  • You have access
    Role of transforming growth factor-beta 1 on platelet-induced enhancement of endothelin-1 production in cultured vascular endothelial cells.
    S Murata, Y Matsumura, K Takada, Y Asai, M Takaoka and S Morimoto
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1524-1530;
  • You have access
    Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.
    C C Chan, S Boyce, C Brideau, A W Ford-Hutchinson, R Gordon, D Guay, R G Hill, C S Li, J Mancini and M Penneton
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1531-1537;
  • You have access
    Regulation of dihydropyridine-sensitive Ca++ channels during opioid tolerance and supersensitivity in rats.
    A Díaz, F Ruíz, J Flórez, A Pazos and M A Hurlé
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1538-1544;
  • You have access
    Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system.
    A Diaz, F Ruiz, J Flórez, M A Hurlé and A Pazos
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1545-1551;
  • You have access
    Selective modulation of elements of the immune system by low molecular weight nucleosides.
    M G Goodman, A B Reitz, R Chen, M D Bobardt, J H Goodman and B L Pope
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1552-1557;
  • You have access
    [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    S L Gackenheimer, J M Schaus and D R Gehlert
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1558-1565;
  • You have access
    Characterization of a delta opioid receptor in rat pheochromocytoma cells.
    M E Abood and Q Tao
    Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1566-1573;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 274, Issue 3
1 Sep 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics